about 2 hours ago
- FOSTER STOCKBROKING
- Stockbroker
Gold stocks to buy on the back of stalling US policy and growth
Heightened expectations of US growth are fading in light of no new economic data to suggest the promised fillip. The efforts of the new Trump administration continue to be frustrated on a number of fronts and cannot point to any meaningful progress so far (Obamacare repeal, debt ceiling, and other self-inflicted distractions). Global markets have been patient so far on US policy implementation, but who knows for how much longer? There appears to be a dawning realisation that progress on any policy front in the US will be slow, if at all, as demonstrated by the failed Obamacare repeal attempt.
The US dollar Index has fallen 1.8% since the start of the year, despite a very brief recovery through February. Markets are no longer as certain of further rate increases during the year, and the slower than expected US rate hike cycle will be supportive of gold prices in the near term.
Recent dovish statements and March minutes from the US Fed have dampened expectations of the expected three rate increases in the US this year and revealed concerns of an overvalued US equities market. 10 year US Treasury bond yields have fallen in the past fortnight, while the yield curve spread between 10-year and 2-year Treasuries have narrowed ~30bps to 2.3%.
Current volatility (VIX 12.39) remains low compared to historical levels (10 year average of 20.70), and with the above headwinds, we believe gold is the way to hedge against USD weakness and slowing US growth.
We recommend a basket of gold equities from the following companies: Beadell Resources, Dacian Gold, Evolution Mining, Northern Star Resources, Perseus Mining, Regis Resources, Resolute Mining, Saracen Mineral, and St Barbara Mining.
- Forums
- ASX - By Stock
- SBM
- Ann: Production Update Q3 March 2017
Ann: Production Update Q3 March 2017, page-24
Featured News
Add SBM (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
0.005(1.45%) |
Mkt cap ! $233.2M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 34.3¢ | $1.551M | 4.447M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 124478 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 272870 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32500 | 3.430 |
9 | 72187 | 3.420 |
11 | 203897 | 3.410 |
9 | 117260 | 3.400 |
11 | 118353 | 3.390 |
Price($) | Vol. | No. |
---|---|---|
3.440 | 192470 | 22 |
3.450 | 143302 | 12 |
3.460 | 61139 | 4 |
3.470 | 41621 | 7 |
3.480 | 81907 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
SBM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online